IPO Boutique

Entellus Medical IPO Advisory

Share this IPO Profile:

Smart Search
Company begins with...
Company contains...

For IPO Boutique's "scale of 1 to 5" BUY rating on Entellus Medical, and our comprehensive analysis, click "Buy Market Research".
Company
Symbol
Price Range
Issue Price
Open
Shares
Trade Date
Entellus MedicalENTL -
NASDAQ
$15.00-$17.00 $17.00 $19.264.6 million1/29/2015
BofA Merrill Lynch, Piper Jaffray
Co-Manager(s):
William Blair, Canaccord Genuity
Health Care
Filing(s):

Filed 2014-12-23
Terms Added 2015-01-15



Entellus Medical Quote & Chart - Click for current quote - ENTL

About Entellus Medical (adapted from Entellus Medical prospectus):
They are a medical technology company focused on the design, development and commercialization of products for the minimally invasive treatment of patients in the physician office setting or operating room who are suffering from chronic sinusitis.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.



IPO Boutique aggregates information on public companies and private companies, such as "ENTL" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.

Used our Comprehensive Single Promo Advisory and want more?
We also offer a monthly or annual subscription






© 2005 - 2024 IPO Boutique. All Rights Reserved